Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
1.240
-0.050 (-3.88%)
Dec 26, 2025, 4:00 PM EST - Market closed
Calidi Biotherapeutics Market Cap
Calidi Biotherapeutics has a market cap or net worth of $9.07 million as of December 26, 2025. Its market cap has decreased by -75.28% in one year.
Market Cap
9.07M
Enterprise Value
2.01M
1-Year Change
-75.28%
Ranking
Category
Stock Price
$1.24
Market Cap Chart
Since November 1, 2021, Calidi Biotherapeutics's market cap has decreased from $273.84M to $9.07M, a decrease of -96.69%. That is a compound annual growth rate of -55.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 9.07M | -59.15% |
| Dec 31, 2024 | 22.21M | -58.52% |
| Dec 29, 2023 | 53.55M | -46.69% |
| Dec 30, 2022 | 100.46M | -64.38% |
| Dec 30, 2021 | 282.04M | 2.99% |
| Nov 1, 2021 | 273.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.58B |
| Johnson & Johnson | 500.68B |
| AbbVie | 406.36B |
| UnitedHealth Group | 298.97B |
| AstraZeneca | 286.29B |
| Novartis AG | 267.64B |
| Merck & Co. | 264.29B |
| Novo Nordisk | 232.28B |